相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Long-Term Survival With Tafamidis in Patients With Transthyretin Amyloid Cardiomyopathy
Perry Elliott et al.
CIRCULATION-HEART FAILURE (2022)
Epidemiology of cardiomyopathies and incident heart failure in a population-based cohort study
Jack R. W. Brownrigg et al.
HEART (2022)
Cardiac device implantation and device usage in Fabry and hypertrophic cardiomyopathy
Ravi Vijapurapu et al.
ORPHANET JOURNAL OF RARE DISEASES (2022)
Common genetic variants and modifiable risk factors underpin hypertrophic cardiomyopathy susceptibility and expressivity
Andrew R. Harper et al.
NATURE GENETICS (2021)
Time to Think Differently About Sarcomere-Negative Hypertrophic Cardiomyopathy
Hugh Watkins
CIRCULATION (2021)
Valsartan in early-stage hypertrophic cardiomyopathy: a randomized phase 2 trial
Carolyn Y. Ho et al.
NATURE MEDICINE (2021)
Mortality Among Referral Patients With Hypertrophic Cardiomyopathy vs the General European Population
Massimiliano Lorenzini et al.
JAMA CARDIOLOGY (2020)
Comparison of Outcomes of Alcohol Septal Ablation or Septal Myectomy for Hypertrophic Cardiomyopathy in Patients ≤65 Years Versus >65 Years
Alejandro Lemor et al.
AMERICAN JOURNAL OF CARDIOLOGY (2020)
Penetrance of Hypertrophic Cardiomyopathy in Sarcomere Protein Mutation Carriers
Massimiliano Lorenzini et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
Iacopo Olivotto et al.
LANCET (2020)
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy
Steve R. Ommen et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Hypertrophic Cardiomyopathy-Related Sudden Cardiac Death in Young People in Ontario
Adaya Weissler-Snir et al.
CIRCULATION (2019)
Distinct Subgroups in Hypertrophic Cardiomyopathy in the NHLBI HCM Registry
Stefan Neubauer et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Long-term outcomes for different surgical strategies to treat left ventricular outflow tract obstruction in hypertrophic cardiomyopathy
Richard Collis et al.
EUROPEAN JOURNAL OF HEART FAILURE (2018)
Identifying unmet clinical need in hypertrophic cardiomyopathy using national electronic health records
Mar Pujades-Rodriguez et al.
PLOS ONE (2018)
International External Validation Study of the 2014 European Society of Cardiology Guidelines on Sudden Cardiac Death Prevention in Hypertrophic Cardiomyopathy (EVIDENCE-HCM)
Constantinos O'Mahony et al.
CIRCULATION (2018)
Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights From the Sarcomeric Human Cardiomyopathy Registry (SHaRe)
Carolyn Y. Ho et al.
CIRCULATION (2018)
Prevalence and clinical phenotype of hereditary transthyretin amyloid cardiomyopathy in patients with increased left ventricular wall thickness
Thibaud Damy et al.
EUROPEAN HEART JOURNAL (2016)
Phenotype and prognostic correlations of the converter region mutations affecting the β myosin heavy chain
Diego Garcia-Giustiniani et al.
HEART (2015)
A Systematic Review and Meta-Analysis of Long-Term Outcomes After Septal Reduction Therapy in Patients With Hypertrophic Cardiomyopathy
Max Liebregts et al.
JACC-HEART FAILURE (2015)
Novel genotype-phenotype associations demonstrated by high-throughput sequencing in patients with hypertrophic cardiomyopathy
Luis R. Lopes et al.
HEART (2015)
Sudden Cardiac Death in Hypertrophic Cardiomyopathy
Constantinos O'Mahony et al.
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2013)
Burden of Rare Sarcomere Gene Variants in the Framingham and Jackson Heart Study Cohorts
Alexander G. Bick et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2012)
Late benefits of dual-chamber pacing in obstructive hypertrophic cardiomyopathy: a 10-year follow-up study
Enrique Galve et al.
HEART (2010)
Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy
G. Lin et al.
HEART (2009)
Hypertrophic cardiomyopathy: lessons from history
C. J. Coats et al.
HEART (2008)
Surgical septal myectomy decreases the risk for appropriate implantable cardioverter defibrillator discharge in obstructive hypertrophic cardiomyopathy
Christopher J. McLeod et al.
EUROPEAN HEART JOURNAL (2007)
Determinants of implantable defibrillator discharges in high-risk patients with hypertrophic cardiomyopathy
Anna Woo et al.
HEART (2007)
Historical trends in reported survival rates in patients with hypertrophic cardiomyopathy
P. M. Elliott et al.
HEART (2006)
Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy
SR Ommen et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy
B Sachdev et al.
CIRCULATION (2002)
分享论文
